Morgan Stanley’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,550,262
| Closed | -$36.8M | – | 8006 |
|
|
2023
Q3 | $36.8M | Buy |
1,550,262
+864,031
| +126% | +$16.3M | ﹤0.01% | 1863 |
|
|
2023
Q2 | $11.1M | Sell |
686,231
-6,987
| -1% | -$116K | ﹤0.01% | 3052 |
|
|
2023
Q1 | $12.1M | Sell |
693,218
-31,950
| -4% | -$574K | ﹤0.01% | 2966 |
|
|
2022
Q4 | $13.6M | Buy |
725,168
+113,311
| +19% | +$2.18M | ﹤0.01% | 2749 |
|
|
2022
Q3 | $10.8M | Sell |
611,857
-101,512
| -14% | -$1.76M | ﹤0.01% | 2878 |
|
|
2022
Q2 | $12.4M | Buy |
713,369
+294,476
| +70% | +$5.61M | ﹤0.01% | 2839 |
|
|
2022
Q1 | $8.76M | Sell |
418,893
-69,114
| -14% | -$1.32M | ﹤0.01% | 3067 |
|
|
2021
Q4 | $8.68M | Sell |
488,007
-217,048
| -31% | -$3.49M | ﹤0.01% | 3098 |
|
|
2021
Q3 | $9.94M | Buy |
705,055
+245,671
| +53% | +$3.82M | ﹤0.01% | 2893 |
|
|
2021
Q2 | $7.62M | Buy |
459,384
+49,980
| +12% | +$896K | ﹤0.01% | 3305 |
|
|
2021
Q1 | $7.41M | Buy |
409,404
+41,397
| +11% | +$817K | ﹤0.01% | 2986 |
|
|
2020
Q4 | $6.71M | Buy |
368,007
+18,612
| +5% | +$295K | ﹤0.01% | 2937 |
|
|
2020
Q3 | $4.45M | Buy |
349,395
+175,916
| +101% | +$2.25M | ﹤0.01% | 2824 |
|
|
2020
Q2 | $1.91M | Buy |
173,479
+14,575
| +9% | +$151K | ﹤0.01% | 3645 |
|
|
2020
Q1 | $1.66M | Sell |
158,904
-111,692
| -41% | -$1.44M | ﹤0.01% | 3522 |
|
|
2019
Q4 | $4.35M | Sell |
270,596
-58,900
| -18% | -$973K | ﹤0.01% | 3343 |
|
|
2019
Q3 | $5.16M | Sell |
329,496
-20,985
| -6% | -$349K | ﹤0.01% | 2844 |
|
|
2019
Q2 | $6.97M | Buy |
350,481
+66,899
| +24% | +$1.25M | ﹤0.01% | 2562 |
|
|
2019
Q1 | $4.77M | Buy |
283,582
+160,467
| +130% | +$2.78M | ﹤0.01% | 2763 |
|
|
2018
Q4 | $1.86M | Buy |
123,115
+1,380
| +1% | +$23.7K | ﹤0.01% | 3830 |
|
|
2018
Q3 | $2.44M | Sell |
121,735
-34,580
| -22% | -$733K | ﹤0.01% | 3849 |
|
|
2018
Q2 | $3.05M | Sell |
156,315
-4,883
| -3% | -$77.2K | ﹤0.01% | 3680 |
|
|
2018
Q1 | $2.2M | Sell |
161,198
-43,980
| -21% | -$579K | ﹤0.01% | 3916 |
|
|
2017
Q4 | $2.79M | Sell |
205,178
-13,214
| -6% | -$190K | ﹤0.01% | 3718 |
|
|
2017
Q3 | $3.44M | Buy |
218,392
+143,499
| +192% | +$2.32M | ﹤0.01% | 3358 |
|
|
2017
Q2 | $1.29M | Sell |
74,893
-182,032
| -71% | -$2.77M | ﹤0.01% | 4182 |
|
|
2017
Q1 | $3.92M | Sell |
256,925
-5,616
| -2% | -$82.7K | ﹤0.01% | 3125 |
|
|
2016
Q4 | $3.45M | Buy |
262,541
+147,498
| +128% | +$1.89M | ﹤0.01% | 3378 |
|
|
2016
Q3 | $1.3M | Sell |
115,043
-339,974
| -75% | -$4.08M | ﹤0.01% | 3830 |
|
|
2016
Q2 | $5.42M | Buy |
455,017
+223,975
| +97% | +$3.01M | ﹤0.01% | 2542 |
|
|
2016
Q1 | $3.52M | Buy |
231,042
+25,091
| +12% | +$381K | ﹤0.01% | 2843 |
|
|
2015
Q4 | $3.32M | Buy |
205,951
+36,013
| +21% | +$526K | ﹤0.01% | 3054 |
|
|
2015
Q3 | $2.12M | Sell |
169,938
-264,354
| -61% | -$3.63M | ﹤0.01% | 3457 |
|
|
2015
Q2 | $7.2M | Buy |
434,292
+139,196
| +47% | +$2.24M | ﹤0.01% | 2448 |
|
|
2015
Q1 | $4.71M | Buy |
295,096
+157,517
| +114% | +$2.61M | ﹤0.01% | 2809 |
|
|
2014
Q4 | $2.15M | Buy |
137,579
+33,709
| +32% | +$493K | ﹤0.01% | 3505 |
|
|
2014
Q3 | $1.43M | Sell |
103,870
-51,304
| -33% | -$778K | ﹤0.01% | 3723 |
|
|
2014
Q2 | $2.49M | Sell |
155,174
-41,024
| -21% | -$649K | ﹤0.01% | 3307 |
|
|
2014
Q1 | $3.31M | Sell |
196,198
-239,712
| -55% | -$4.35M | ﹤0.01% | 2984 |
|
|
2013
Q4 | $9.18M | Sell |
435,910
-120,441
| -22% | -$2.71M | ﹤0.01% | 2017 |
|
|
2013
Q3 | $12.1M | Buy |
556,351
+324,570
| +140% | +$6.93M | 0.01% | 1621 |
|
|
2013
Q2 | $4.34M | Buy |
+231,781
| New | +$4.23M | ﹤0.01% | 2466 |
|
Other funds holding NXGN
Morgan Stanley's NXGN Position: Q4 2023 in Review
Morgan Stanley sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 1,550,262 shares — an estimated $36.8M sold.
Morgan Stanley first reported a position in NXGN in Q2 2013 and held it in 42 quarters. The position peaked at $36.8M in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Morgan Stanley reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Morgan Stanley sold 1,550,262 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $36.8M.
- Morgan Stanley first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
- Morgan Stanley's NextGen Healthcare, Inc. Common Stock position peaked at $36.8M in Q3 2023.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.